Skip to main content
. 2013 Dec;61(12):705–710. doi: 10.4103/0301-4738.124750

Figure 1.

Figure 1

Effect of 5 days exposure of bevacizumab at 0.125, 0.25, 0.50 and 1 mg/ml on the mitochondrial dehydrogenase activity of human retinal pigment epithelial (ARPE-19) cells in culture. The mean mitochondrial dehydrogenase activity of ARPE-19 cells treated with bevacizumab was not significantly different (P > 0.05) compared to the controls